Arvinas, Inc. (ARVN)
9.60
+0.26
(+2.78%)
USD |
NASDAQ |
Aug 25, 16:00
9.60
0.00 (0.00%)
After-Hours: 19:59
Arvinas Total Assets (Quarterly) : 675.10M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 675.10M |
| March 31, 2026 | 647.50M |
| December 31, 2025 | 717.90M |
| September 30, 2025 | 844.30M |
| June 30, 2025 | 909.30M |
| March 31, 2025 | 1.001B |
| December 31, 2024 | 1.091B |
| September 30, 2024 | 1.167B |
| June 30, 2024 | 1.280B |
| March 31, 2024 | 1.213B |
| December 31, 2023 | 1.305B |
| September 30, 2023 | 1.058B |
| June 30, 2023 | 1.084B |
| March 31, 2023 | 1.176B |
| December 31, 2022 | 1.269B |
| September 30, 2022 | 1.335B |
| June 30, 2022 | 1.407B |
| March 31, 2022 | 1.488B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.587B |
| September 30, 2021 | 1.605B |
| June 30, 2021 | 644.03M |
| March 31, 2021 | 681.77M |
| December 31, 2020 | 719.79M |
| September 30, 2020 | 271.95M |
| June 30, 2020 | 262.58M |
| March 31, 2020 | 282.45M |
| December 31, 2019 | 302.97M |
| September 30, 2019 | 209.09M |
| June 30, 2019 | 172.05M |
| March 31, 2019 | 186.57M |
| December 31, 2018 | 199.28M |
| September 30, 2018 | 98.89M |
| June 30, 2018 | 105.99M |
| March 31, 2018 | 116.28M |
| December 31, 2017 | 66.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 323.95M |
| Definium Therapeutics, Inc. | 1.113B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 112.90M |
| Shareholders Equity (Quarterly) | 562.20M |
| Debt to Equity Ratio | 0.0146 |
| Current Ratio | 7.906 |
| Net Debt Paydown Yield | 0.09% |